Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 383
5
Diseases
18
Unique genes
0.180
Avg. similarity score
C1 esterase inhibitor deficiency
Most-connected disease (4 links)
Disease
Searched: Hereditary c1 esterase inhibitor deficiency
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hereditary c1 esterase inhibitor deficiency
C1 esterase inhibitor deficiency
Complement component deficiency
C9 deficiency
Terminal complement component deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| C1 esterase inhibitor deficiency | 4 | 4 | 6 |
| Complement component deficiency | 4 | 4 | 17 |
| C9 deficiency | 3 | 3 | 1 |
| Terminal complement component deficiency | 3 | 3 | 7 |
| Hereditary c1 esterase inhibitor deficiency | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| C9 | 4 / 5 | C1 esterase inhibitor deficiency, C9 deficiency, Complement component deficiency, Terminal complement component deficiency |
| C8A | 3 / 5 | C1 esterase inhibitor deficiency, Complement component deficiency, Terminal complement component deficiency |
| C8B | 3 / 5 | C1 esterase inhibitor deficiency, Complement component deficiency, Terminal complement component deficiency |
| SERPING1 | 3 / 5 | C1 esterase inhibitor deficiency, Complement component deficiency, Hereditary c1 esterase inhibitor deficiency |
| C2 | 2 / 5 | C1 esterase inhibitor deficiency, Complement component deficiency |
| C4B | 2 / 5 | C1 esterase inhibitor deficiency, Complement component deficiency |
| C5 | 2 / 5 | Complement component deficiency, Terminal complement component deficiency |
| C6 | 2 / 5 | Complement component deficiency, Terminal complement component deficiency |
| C7 | 2 / 5 | Complement component deficiency, Terminal complement component deficiency |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Regulation of Complement cascade | Reactome | 16 / 47 | 227× | 2.58e-38 | 1.59e-34 ✓ sig. |
| Complement and coagulation cascades | KEGG | 17 / 88 | 129× | 1.75e-36 | 8.48e-33 ✓ sig. |
| Coronavirus disease - COVID-19 | KEGG | 14 / 238 | 39.2× | 2.80e-21 | 2.45e-18 ✓ sig. |
| Terminal pathway of complement | Reactome | 7 / 8 | 584× | 3.56e-20 | 2.66e-17 ✓ sig. |
| Systemic lupus erythematosus | KEGG | 12 / 140 | 57.2× | 6.82e-20 | 4.86e-17 ✓ sig. |
| Staphylococcus aureus infection | KEGG | 10 / 99 | 67.4× | 3.77e-17 | 1.77e-14 ✓ sig. |
| Activation of C3 and C5 | Reactome | 6 / 8 | 500× | 1.25e-16 | 5.38e-14 ✓ sig. |
| Pertussis | KEGG | 7 / 78 | 59.9× | 1.11e-11 | 2.00e-9 ✓ sig. |
| Initial triggering of complement | Reactome | 4 / 17 | 157× | 8.30e-9 | 7.81e-7 ✓ sig. |
| Regulation of actin cytoskeleton | KEGG | 7 / 232 | 20.1× | 2.44e-8 | 2.01e-6 ✓ sig. |
| Alternative complement activation | Reactome | 3 / 5 | 400× | 2.82e-8 | 2.29e-6 ✓ sig. |
| Prion disease | KEGG | 7 / 275 | 17.0× | 7.84e-8 | 5.66e-6 ✓ sig. |
| Alcoholic liver disease | KEGG | 5 / 144 | 23.2× | 1.75e-6 | 8.45e-5 ✓ sig. |
| Amoebiasis | KEGG | 4 / 103 | 25.9× | 1.42e-5 | 4.74e-4 ✓ sig. |
| Post-translational protein phosphorylation | Reactome | 3 / 108 | 18.5× | 5.23e-4 | 8.56e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| complement activation | GO:0006956 | 16 / 35 | 475× | 5.90e-44 | 7.45e-40 ✓ sig. |
| complement activation, GZMK pathway | GO:0160257 | 11 / 12 | 952× | 1.58e-34 | 1.05e-30 ✓ sig. |
| complement activation, classical pathway | GO:0006958 | 13 / 37 | 365× | 5.60e-33 | 3.60e-29 ✓ sig. |
| complement activation, alternative pathway | GO:0006957 | 10 / 16 | 649× | 2.45e-28 | 1.14e-24 ✓ sig. |
| killing of cells of another organism | GO:0031640 | 12 / 104 | 120× | 8.28e-24 | 2.34e-20 ✓ sig. |
| innate immune response | GO:0045087 | 16 / 605 | 27.5× | 1.73e-22 | 3.97e-19 ✓ sig. |
| immune system process | GO:0002376 | 16 / 943 | 17.6× | 2.18e-19 | 3.08e-16 ✓ sig. |
| activation of membrane attack complex | GO:0001905 | 5 / 13 | 399× | 5.78e-13 | 2.76e-10 ✓ sig. |
| positive regulation of immune response | GO:0050778 | 6 / 40 | 156× | 1.18e-12 | 5.40e-10 ✓ sig. |
| opsonization | GO:0008228 | 5 / 18 | 288× | 3.84e-12 | 1.58e-9 ✓ sig. |
| positive regulation of apoptotic cell clearance | GO:2000427 | 4 / 6 | 692× | 9.03e-12 | 3.36e-9 ✓ sig. |
| complement activation, lectin pathway | GO:0001867 | 4 / 13 | 319× | 4.28e-10 | 1.06e-7 ✓ sig. |
| protein maturation | GO:0051604 | 6 / 134 | 46.5× | 2.10e-9 | 4.34e-7 ✓ sig. |
| immune response | GO:0006955 | 6 / 543 | 11.5× | 8.07e-6 | 4.57e-4 ✓ sig. |
| response to bacterium | GO:0009617 | 4 / 140 | 29.7× | 8.51e-6 | 4.77e-4 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| C1 esterase inhibitor deficiency | Complement component deficiency | 0.333 | 6 | 6.69e-19 | 1.20e-17 ✓ sig. |
| Complement component deficiency | Terminal complement component deficiency | 0.316 | 6 | 4.68e-18 | 8.09e-17 ✓ sig. |
| C1 esterase inhibitor deficiency | Terminal complement component deficiency | 0.273 | 3 | 1.15e-9 | 1.04e-8 ✓ sig. |
| C1 esterase inhibitor deficiency | Hereditary c1 esterase inhibitor deficiency | 0.143 | 1 | 3.90e-4 | 8.67e-4 ✓ sig. |
| C1 esterase inhibitor deficiency | C9 deficiency | 0.143 | 1 | 3.90e-4 | 8.67e-4 ✓ sig. |
| C9 deficiency | Terminal complement component deficiency | 0.125 | 1 | 4.55e-4 | 9.73e-4 ✓ sig. |
| C9 deficiency | Complement component deficiency | 0.056 | 1 | 1.10e-3 | 1.83e-3 ✓ sig. |
| Complement component deficiency | Hereditary c1 esterase inhibitor deficiency | 0.056 | 1 | 1.10e-3 | 1.83e-3 ✓ sig. |